48,830
edits
Line 84: | Line 84: | ||
*Immunostains useful to separate prostate carcinoma from [[SV]] are discussed in the ''[[seminal vesicle]]'' article. | *Immunostains useful to separate prostate carcinoma from [[SV]] are discussed in the ''[[seminal vesicle]]'' article. | ||
*It is not possible to differentiate the ''seminal vesicles'' and ''ejaculatory ducts'' based only on histology; thus, on biopsy one can generally comment only on ''seminal vesicle/ejaculatory duct invasion''. | *It is not possible to differentiate the ''seminal vesicles'' and ''ejaculatory ducts'' based only on histology; thus, on biopsy one can generally comment only on ''seminal vesicle/ejaculatory duct invasion''. | ||
*SVI has been subdivided into three types (type I: spread along ejaculatory duct complex, type II: through prostate capsule and then into SV; type III: discontinuous spread/metastasis).<ref name=pmid16985773>{{Cite journal | last1 = Potter | first1 = SR. | last2 = Epstein | first2 = JI. | last3 = Partin | first3 = AW. | title = Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications. | journal = Rev Urol | volume = 2 | issue = 3 | pages = 190-5 | month = | year = 2000 | doi = | PMID = 16985773 }}</ref> | *SVI has been subdivided into three types by pattern of spread (type I: spread along ejaculatory duct complex, type II: through prostate capsule and then into SV; type III: discontinuous spread/metastasis).<ref name=pmid16985773>{{Cite journal | last1 = Potter | first1 = SR. | last2 = Epstein | first2 = JI. | last3 = Partin | first3 = AW. | title = Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications. | journal = Rev Urol | volume = 2 | issue = 3 | pages = 190-5 | month = | year = 2000 | doi = | PMID = 16985773 }}</ref> | ||
===Lymph node=== | ===Lymph node=== |
edits